Medpace Holdings Inc
MEDP590.090USD
-1.230-0.21%
收盤 11/14, 16:00（美東）報價延遲15分鐘
16.58B總市值
38.29本益比TTM
關於 Medpace Holdings Inc 公司
Medpace Holdings, Inc. 是一家以科學爲導向的全球性全方位臨牀合同研究組織 (CRO)，爲生物技術、製藥和醫療器械行業提供 I-IV 期臨牀開發服務。該公司與製藥、生物技術和醫療器械公司合作開發和執行臨牀試驗。該公司的藥物開發服務專注於全方位 I-IV 期臨牀開發服務，包括開發計劃設計、協調中心實驗室、項目管理、監管事務、臨牀監測、數據管理和分析、藥物警戒新藥申請提交和上市後臨牀支持。該公司還爲臨牀試驗提供生物分析實驗室服務、臨牀人體藥理學、成像服務和心電圖閱讀支持。該公司的業務主要位於北美、歐洲和亞洲。
Medpace Holdings Inc簡介
公司代碼MEDP
公司名稱Medpace Holdings Inc
上市日期Aug 11, 2016
CEODr. August J. Troendle, M.D.
員工數量5900
證券類型Ordinary Share
年結日Aug 11
公司地址5375 Medpace Way
城市CINCINNATI
上市交易所NASDAQ Global Select Consolidated
國家United States of America
郵編45227-1543
電話15135799911
網址https://investor.medpace.com/
公司代碼MEDP
上市日期Aug 11, 2016
CEODr. August J. Troendle, M.D.
Medpace Holdings Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. August J. Troendle, M.D.
Dr. August J. Troendle, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
914.16K
-1.13%
Mr. Brian T. Carley
Mr. Brian T. Carley
Independent Director
Independent Director
26.28K
+0.24%
Mr. Jesse J. Geiger, CPA
Mr. Jesse J. Geiger, CPA
President
President
15.00K
-58.91%
Mr. Stephen P. Ewald, J.D.
Mr. Stephen P. Ewald, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
13.34K
+29.01%
Mr. Robert O. Kraft
Mr. Robert O. Kraft
Independent Director
Independent Director
890.00
+6.84%
Dr. Dani S. Zander
Dr. Dani S. Zander
Independent Director
Independent Director
--
--
Mr. Cornelius P. Mccarthy, III
Mr. Cornelius P. Mccarthy, III
Independent Director
Independent Director
--
--
Mr. Kevin M. Brady
Mr. Kevin M. Brady
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
--
--
Mr. Fred B. Davenport, Jr.
Mr. Fred B. Davenport, Jr.
Lead Independent Director
Lead Independent Director
--
--
Ms. Susan E. Burwig
Ms. Susan E. Burwig
Executive Vice President - Operations
Executive Vice President - Operations
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Dr. August J. Troendle, M.D.
Dr. August J. Troendle, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
914.16K
-1.13%
Mr. Brian T. Carley
Mr. Brian T. Carley
Independent Director
Independent Director
26.28K
+0.24%
Mr. Jesse J. Geiger, CPA
Mr. Jesse J. Geiger, CPA
President
President
15.00K
-58.91%
Mr. Stephen P. Ewald, J.D.
Mr. Stephen P. Ewald, J.D.
General Counsel, Corporate Secretary
General Counsel, Corporate Secretary
13.34K
+29.01%
Mr. Robert O. Kraft
Mr. Robert O. Kraft
Independent Director
Independent Director
890.00
+6.84%
Dr. Dani S. Zander
Dr. Dani S. Zander
Independent Director
Independent Director
--
--
收入明細
單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
業務USD
名稱
營收
佔比
Oncology
188.56M
31.25%
Metabolic
147.87M
24.51%
Other
118.06M
19.57%
Central Nervous System
61.13M
10.13%
Cardiology
58.58M
9.71%
AVAI
29.11M
4.82%
暫無數據
業務
地區
業務USD
名稱
營收
佔比
Oncology
188.56M
31.25%
Metabolic
147.87M
24.51%
Other
118.06M
19.57%
Central Nervous System
61.13M
10.13%
Cardiology
58.58M
9.71%
AVAI
29.11M
4.82%
股東統計
更新時間: 7 小時前
更新時間: 7 小時前
持股股東
股東類型
持股股東
持股股東
佔比
Medpace Investors, L.L.C.
16.80%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
7.47%
AQR Capital Management, LLC
3.64%
Wasatch Global Investors Inc
3.29%
其他
60.71%
持股股東
持股股東
佔比
Medpace Investors, L.L.C.
16.80%
The Vanguard Group, Inc.
8.08%
BlackRock Institutional Trust Company, N.A.
7.47%
AQR Capital Management, LLC
3.64%
Wasatch Global Investors Inc
3.29%
其他
60.71%
股東類型
持股股東
佔比
Investment Advisor
47.29%
Investment Advisor/Hedge Fund
25.63%
Corporation
16.80%
Hedge Fund
7.30%
Research Firm
4.31%
Individual Investor
3.73%
Pension Fund
2.61%
Family Office
1.65%
Family Office
1.65%
機構持股
更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
1221
26.75M
94.97%
-1.63M
2025Q2
1184
32.22M
114.46%
-1.64M
2025Q1
1189
32.19M
111.84%
-1.65M
2024Q4
1154
31.87M
104.30%
-1.77M
2024Q3
1089
31.75M
102.26%
-1.23M
2024Q2
1042
31.55M
102.01%
-1.83M
2024Q1
995
31.67M
102.27%
-1.17M
2023Q4
938
31.80M
103.67%
-407.87K
2023Q3
885
31.39M
102.53%
-1.87M
2023Q2
840
32.05M
105.05%
-2.06M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Medpace Investors, L.L.C.
4.73M
16.85%
--
--
Mar 20, 2025
The Vanguard Group, Inc.
2.38M
8.49%
-142.86K
-5.65%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.22M
7.89%
-198.04K
-8.20%
Jun 30, 2025
AQR Capital Management, LLC
621.18K
2.21%
+81.64K
+15.13%
Jun 30, 2025
Wasatch Global Investors Inc
945.81K
3.37%
+116.35K
+14.03%
Jun 30, 2025
Troendle (August J)
924.60K
3.29%
-1.20K
-0.13%
Sep 02, 2025
State Street Investment Management (US)
706.78K
2.52%
-76.21K
-9.73%
Jun 30, 2025
Mawer Investment Management Ltd.
817.43K
2.91%
+121.21K
+17.41%
Jun 30, 2025
Geode Capital Management, L.L.C.
637.93K
2.27%
-30.28K
-4.53%
Jun 30, 2025
D. E. Shaw & Co., L.P.
343.56K
1.22%
+129.38K
+60.41%
Jun 30, 2025
查看更多
持股ETF
更新時間: 11月6日 週四
更新時間: 11月6日 週四
機構名稱
佔比
Invesco Dorsey Wright Healthcare Momentum ETF
5.26%
Franklin Genomic Advancements ETF
5.07%
Argent Mid Cap ETF
4.57%
Invesco S&P MidCap Quality ETF
3.79%
Congress SMid Growth ETF
3.24%
ERShares Entrepreneurs ETF
3.24%
Janus Henderson Small/Mid Cap Growth Alpha ETF
3.08%
Invesco S&P MidCap 400 GARP ETF
2.97%
Aztlan Global Stock Selection DM SMID ETF
2.31%
Pacer US Large Cap Cash Cows Growth Leaders ETF
2.14%
查看更多
Invesco Dorsey Wright Healthcare Momentum ETF
佔比5.26%
Franklin Genomic Advancements ETF
佔比5.07%
Argent Mid Cap ETF
佔比4.57%
Invesco S&P MidCap Quality ETF
佔比3.79%
Congress SMid Growth ETF
佔比3.24%
ERShares Entrepreneurs ETF
佔比3.24%
Janus Henderson Small/Mid Cap Growth Alpha ETF
佔比3.08%
Invesco S&P MidCap 400 GARP ETF
佔比2.97%
Aztlan Global Stock Selection DM SMID ETF
佔比2.31%
Pacer US Large Cap Cash Cows Growth Leaders ETF
佔比2.14%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
